THE THERATEST EL-B2GP1 (IGM, IGG, IGA) AND EL-B2GP1SCR

System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)

THERATEST LABORATORIES, INC.

The following data is part of a premarket notification filed by Theratest Laboratories, Inc. with the FDA for The Theratest El-b2gp1 (igm, Igg, Iga) And El-b2gp1scr.

Pre-market Notification Details

Device IDK972790
510k NumberK972790
Device Name:THE THERATEST EL-B2GP1 (IGM, IGG, IGA) AND EL-B2GP1SCR
ClassificationSystem,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)
Applicant THERATEST LABORATORIES, INC. 2201 WEST CAMPBELL PARK DR. Chicago,  IL  60612 -3501
ContactMarius Teodorescu
CorrespondentMarius Teodorescu
THERATEST LABORATORIES, INC. 2201 WEST CAMPBELL PARK DR. Chicago,  IL  60612 -3501
Product CodeMSV  
CFR Regulation Number866.5660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1997-07-28
Decision Date1997-12-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.